<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01010711</url>
  </required_header>
  <id_info>
    <org_study_id>TOM-DS-CH-1</org_study_id>
    <nct_id>NCT01010711</nct_id>
  </id_info>
  <brief_title>Influence of a Dietary Supplement as Treatment of Migraine in Children and Adolescents</brief_title>
  <official_title>Study for Documentation of the Influence of a Specific Dietary Supplement Treatment of Migraine in Children and Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complen Health GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complen Health GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Migraine in children and adolescents can be associated with low serum levels of coenzyme q10,
      the key-enzyme of mitochondrial energy production.During migraine attacks inflammation is an
      important issue. Based on a double-blind placebo-controlled trial with coenzyme q10 in adults
      it is hypothesized that daily supplementation of coenzyme q10 as well as different
      antioxidative phytochemicals (from berries) and specific minerals and vitamins are able to
      reduce the &quot;days with migraine&quot; as primary parameter (open clinical trial).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children or adolescents with migraine and both parents are informed in detail about the
      study.Probands are advised to fill in a special childrens´ diary for migraine daily. After a
      4 week-run-in period they start to take the dietary supplement (powder to be dissolved in
      water)plus a capsule with omega-3-fatty acids from fish oil for 12 weeks daily. Afterwards
      there is a follow-up without supplement treatment for another 12 weeks.76 participants will
      be included in the trial for statistical evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">April 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of days with headache before and after 12 weeks of daily treatment with a migraine specific dietary supplement</measure>
    <time_frame>headaches before and after 12 weeks of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>frequency, duration and intensity of the migraine</measure>
    <time_frame>before and after 12 weeks of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>migraine dietary supplement</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>the average days of migraine during a 4 week-run-in-period are compared with the average days of migraine during intervention with a &quot;specific dietary supplement&quot; from week 8 - 12</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Migra 3</intervention_name>
    <description>powder containing coenzyme q10, blueberries, black current, vitamins, magnesium,trace elements</description>
    <arm_group_label>migraine dietary supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 3 days of migraine per month

        Exclusion Criteria:

          -  not able to communicate in german or english language

          -  any disease that forbids the participation in the trial according to the investigators
             assessment

          -  pregnancy

          -  no willingness to participate in the trial

          -  known allergy to fish or soya
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charly Gaul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universiätsklinikum Essen Neurologische Klinik, Westdeutsches Kopfschmerzzentrum, Hufelandstr.26, D-45147 Essen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charly Gaul, MD</last_name>
    <phone>0049-201-43696-0</phone>
    <email>Charly.Gaul@gmx.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universiätsklinikum Essen Neurologische Klinik, Westdeutsches Kopfschmerzzentrum, Hufelandstr.26,</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>D-45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charly Gaul, MD</last_name>
      <phone>0049-201-43696-0</phone>
      <email>Charly.Gaul@gmx.de</email>
    </contact>
    <investigator>
      <last_name>Dagny Holle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Migräne und Kopfschmerzklinik Königstein</name>
      <address>
        <city>Königstein Im Taunus</city>
        <zip>61462</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Jan Brand, Dr.</last_name>
      <phone>0049-6174-29040</phone>
      <email>info@migraene-klinik.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2009</study_first_submitted>
  <study_first_submitted_qc>November 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2009</study_first_posted>
  <last_update_submitted>February 1, 2010</last_update_submitted>
  <last_update_submitted_qc>February 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Margarete Doppler</name_title>
    <organization>COMPLEN HEALTH GmbH</organization>
  </responsible_party>
  <keyword>migraine</keyword>
  <keyword>children</keyword>
  <keyword>dietary supplement</keyword>
  <keyword>q10</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

